DK207279A - Fremgangsmaade til fremstilling af e-vitaminpulver - Google Patents

Fremgangsmaade til fremstilling af e-vitaminpulver

Info

Publication number
DK207279A
DK207279A DK207279A DK207279A DK207279A DK 207279 A DK207279 A DK 207279A DK 207279 A DK207279 A DK 207279A DK 207279 A DK207279 A DK 207279A DK 207279 A DK207279 A DK 207279A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
vitamin powder
vitamin
powder
Prior art date
Application number
DK207279A
Other languages
English (en)
Other versions
DK156696B (da
DK156696C (da
Inventor
A Kuipers
H Becker
H Tiefenbacher
H Schumacher
Original Assignee
Basf Ag
Meggle Milchind Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Meggle Milchind Gmbh & Co filed Critical Basf Ag
Publication of DK207279A publication Critical patent/DK207279A/da
Publication of DK156696B publication Critical patent/DK156696B/da
Application granted granted Critical
Publication of DK156696C publication Critical patent/DK156696C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK207279A 1978-05-22 1979-05-21 Fremgangsmaade til fremstilling af e-vitamin-toerpulver DK156696C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2822324 1978-05-22
DE2822324A DE2822324C3 (de) 1978-05-22 1978-05-22 Herstellung von Vitamin-E-Trockenpulver

Publications (3)

Publication Number Publication Date
DK207279A true DK207279A (da) 1979-11-23
DK156696B DK156696B (da) 1989-09-25
DK156696C DK156696C (da) 1990-02-05

Family

ID=6039954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK207279A DK156696C (da) 1978-05-22 1979-05-21 Fremgangsmaade til fremstilling af e-vitamin-toerpulver

Country Status (4)

Country Link
US (1) US4262017A (da)
EP (1) EP0005529B1 (da)
DE (2) DE2822324C3 (da)
DK (1) DK156696C (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062867D1 (en) * 1980-04-01 1983-06-01 Sumitomo Chemical Co Process for the production of water-soluble biotin-containing preparations and their use as additives to feed supplements
US4395422A (en) * 1981-04-06 1983-07-26 Basf Wyandotte Corporation Spray dried vitamin E powder
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
US4617294A (en) * 1985-04-22 1986-10-14 Ppg Industries, Inc. Animal feed supplement
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
BR122018068298B8 (pt) * 2003-08-06 2021-07-27 Gruenenthal Gmbh processo para a produção de um comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) * 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) * 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20080009545A1 (en) * 2006-02-21 2008-01-10 The Ohio State University Research Foundation Anticancer agents
WO2007143081A2 (en) * 2006-06-02 2007-12-13 The Ohio State University Research Foundation Therapeutic agents for the treatment of lymphoid malignancies
DE102007011485A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US8383152B2 (en) 2008-01-25 2013-02-26 Gruenenthal Gmbh Pharmaceutical dosage form
HUE030803T2 (en) * 2008-05-09 2017-06-28 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
EP2419414A4 (en) * 2009-04-13 2013-12-04 Univ Ohio State Res Found AGENTS THAT ACTIVATE PROTEIN PHOSPHATASE 2A
AU2010236323A1 (en) * 2009-04-17 2011-11-24 The Ohio State University Research Foundation Antiadhesion agents
EP2456427B1 (en) 2009-07-22 2015-03-04 Grünenthal GmbH Hot-melt extruded controlled release dosage form
AR077420A1 (es) 2009-07-22 2011-08-24 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion
EP2531176B1 (en) * 2010-02-03 2016-09-07 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of an extruder
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
JP5933553B2 (ja) 2010-09-02 2016-06-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング アニオン性ポリマーを含む不正使用抵抗性剤形
US8309768B2 (en) 2010-11-29 2012-11-13 The Ohio State University Research Foundation FTY720-derived anticancer agents
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
EP2838512B1 (en) 2012-04-18 2018-08-22 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
CN113439841A (zh) 2013-08-29 2021-09-28 雅培公司 具有提高的溶解度和生物利用度的营养组合物
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
EA035434B1 (ru) 2015-04-24 2020-06-15 Грюненталь Гмбх Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
CN107846953A (zh) 2015-07-29 2018-03-27 雅培制药有限公司 呈容易混合形式的具有改善的亲脂性溶解度和生物利用度的营养产品
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE640508A (da) *
US3124510A (en) * 1964-03-10 Stable dry powdered fat-soluble
DE1098798B (de) * 1958-06-27 1961-02-02 Albert Fricke Mastfuttermittel aus frischer oder getrockneter Voll- oder Magermilch
GB919193A (en) * 1958-11-12 1963-02-20 Shinshiro Ohtaki A method for producing powder containing oil or fat
GB1147210A (en) * 1965-06-30 1969-04-02 Eastman Kodak Co Improvements in or relating to vitamins
US3446899A (en) * 1968-01-25 1969-05-27 Hoffmann La Roche Vitamin compositions produced by direct compression
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder
US3914430A (en) * 1972-04-10 1975-10-21 Hoffmann La Roche Free-flowing, high density, agglomerated vitamin E powder compositions
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5421403B2 (da) * 1974-01-18 1979-07-30

Also Published As

Publication number Publication date
DE2822324B2 (de) 1980-06-19
US4262017A (en) 1981-04-14
DK156696B (da) 1989-09-25
EP0005529B1 (de) 1981-01-07
DE2960122D1 (en) 1981-02-26
EP0005529A1 (de) 1979-11-28
DE2822324C3 (de) 1981-02-26
DE2822324A1 (de) 1979-11-29
DK156696C (da) 1990-02-05

Similar Documents

Publication Publication Date Title
DK207279A (da) Fremgangsmaade til fremstilling af e-vitaminpulver
DK149023C (da) Analogifremgangsmaade til fremstilling af tiazolidinderivater
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK294880A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK413780A (da) Fremgangsmaade til fremstilling af d-6-n-propylergoliner
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK147145C (da) Analogifremgangsmaade til fremstilling af chlorambucilderivater
DK161198C (da) Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK177680A (da) Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK157850C (da) Fremgangsmaade til fremstilling af 7-acylindolin-2-oner
DK147183C (da) Fremgangsmaade til fremstilling af l-alfa-glycerophosphatoxidase
DK250679A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin
DK12879A (da) R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate
DK12379A (da) Fremgangsmaade til fremstilling af cysteinholdige peptider
DK260079A (da) Fremgangsmaade til fremstilling af phenoxyalkylamid-derivater

Legal Events

Date Code Title Description
PUP Patent expired